102 related articles for article (PubMed ID: 32082491)
1. Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines.
Timmermans-Sprang E; Collin RWJ; Henkes A; Philipsen M; Mol JA
Oncotarget; 2020 Feb; 11(5):573. PubMed ID: 32082491
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines.
Timmermans-Sprang E; Collin R; Henkes A; Philipsen M; Mol JA
Oncotarget; 2019 Apr; 10(31):2930-2946. PubMed ID: 31105876
[No Abstract] [Full Text] [Related]
3. High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression.
Timmermans-Sprang EP; Gracanin A; Mol JA
BMC Cancer; 2015 Jul; 15():545. PubMed ID: 26205886
[TBL] [Abstract][Full Text] [Related]
4. Correction: The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.
Brodie S; Lee HK; Jiang W; Cazacu S; Xiang C; Poisson LM; Datta I; Kalkanis S; Ginsberg D; Brodie C
Oncotarget; 2021 Dec; 12(26):2546-2547. PubMed ID: 34966487
[TBL] [Abstract][Full Text] [Related]
5. Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin.
Dybdal-Hargreaves NF; Risinger AL; Mooberry SL
Oncotarget; 2019 Jul; 10(45):4719-4720. PubMed ID: 31384398
[TBL] [Abstract][Full Text] [Related]
6. Correction: Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.
Yin SY; Efferth T; Jian FY; Chen YH; Liu CI; Wang AHJ; Chen YR; Hsiao PW; Yang NS
Oncotarget; 2018 Aug; 9(63):32271. PubMed ID: 30181816
[TBL] [Abstract][Full Text] [Related]
7. Metabolite profiling in sphere-forming cells from canine mammary adenocarcinoma cell lines using gas chromatography-mass spectrometry.
Michishita M; Saito N; Nozawa S; Furumoto R; Nakagawa T; Sato T; Ochiai K; Azakami D; Katayama K; Nakahira R; Tazaki H; Machida Y; Ishiwata T
J Vet Med Sci; 2019 Sep; 81(9):1238-1248. PubMed ID: 31308293
[TBL] [Abstract][Full Text] [Related]
8. Correction: An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer.
Yu L; Hua X; Yang Y; Li K; Zhang Q; Yu L
Oncotarget; 2018 Apr; 9(28):20220. PubMed ID: 29733082
[TBL] [Abstract][Full Text] [Related]
9. Correction: 4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression.
Park SA; Lee MH; Na HK; Surh YJ
Oncotarget; 2019 Feb; 10(12):1266. PubMed ID: 30815229
[TBL] [Abstract][Full Text] [Related]
10. Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.
McDonald JT; Kritharis A; Beheshti A; Pilichowska M; Burgess K; Ricks-Santi L; McNiel E; London CA; Ravi D; Evens AM
Oncotarget; 2018 Sep; 9(70):33441. PubMed ID: 30279973
[TBL] [Abstract][Full Text] [Related]
11. Correction: Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
Xie Y; Li P; Gao Y; Gu L; Chen L; Fan Y; Zhang F; Zhang X
Oncotarget; 2019 Apr; 10(27):2657. PubMed ID: 31080556
[TBL] [Abstract][Full Text] [Related]
12. Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression.
Uyama R; Nakagawa T; Hong SH; Mochizuki M; Nishimura R; Sasaki N
Vet Comp Oncol; 2006 Jun; 4(2):104-13. PubMed ID: 19754820
[TBL] [Abstract][Full Text] [Related]
13. Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
Adamo B; Ricciardi GRR; Ieni A; Franchina T; Fazzari C; Sanò MV; Angelico G; Caruso M; Tuccari G; Adamo V
Oncotarget; 2019 Jan; 10(8):917. PubMed ID: 30783520
[TBL] [Abstract][Full Text] [Related]
14. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells.
Su Y; Simmen RC
Carcinogenesis; 2009 Feb; 30(2):331-9. PubMed ID: 19073877
[TBL] [Abstract][Full Text] [Related]
16. Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine.
Jung DB; Yun M; Kim EO; Kim J; Kim B; Jung JH; Wang E; Mukopadhyay D; Hammond E; Dredge K; Shridhar V; Kim SH
Oncotarget; 2019 Sep; 10(54):5669. PubMed ID: 31608142
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling.
Diao H; Cheng N; Zhao Y; Xu H; Dong H; Thamm DH; Zhang D; Lin D
BMC Vet Res; 2019 Aug; 15(1):276. PubMed ID: 31375107
[TBL] [Abstract][Full Text] [Related]
18. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
19. P-cadherin expression in canine mammary tissues.
Gama A; Paredes J; Albergaria A; Gartner F; Schmitt F
J Comp Pathol; 2004 Jan; 130(1):13-20. PubMed ID: 14693120
[TBL] [Abstract][Full Text] [Related]
20. Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.
Petrelli A; Carollo R; Cargnelutti M; Iovino F; Callari M; Cimino D; Todaro M; Mangiapane LR; Giammona A; Cordova A; Montemurro F; Taverna D; Daidone MG; Stassi G; Giordano S
Oncotarget; 2019 Aug; 10(48):5003-5004. PubMed ID: 31452840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
